A case of reactivation of hepatitis B presenting with exudative ascites

1. Hoofnagle . Reactivation of hepatitis B. Hepatology 2009; 49: S156–S165.
Google Scholar | Crossref | Medline | ISI2. Kappus, MR, Sterling, RK. Extrahepatic manifestations of acute hepatitis B virus infection. Gastroenterol Hepatol (N Y) 2013; 9: 123–126.
Google Scholar | Medline3. Abbas, AK . Pathologic basis of disease. 7th ed. Philadelphia: W.B. Saunders; 2004. Diseases of immunity. In: Kumar V, Abbas AK, Fausto N, editors; pp. 193–267.
Google Scholar4. Calvet, X, Bruix, J, Bosch, J, et al. Portal pressure in patients with exudative ascites in the course of acute hepatitis B. Liver 1991; 11: 206–210.
Google Scholar | Crossref5. Viola, C, Vineta, L, Bosch, J, et al. Exudative ascites in the course of acute type B hepatitis. Hepatology 1983; 3: 1013–1015.
Google Scholar | Crossref | Medline6. Valla, D, Flejou, JF, Lebrec, D, et al. Portal hypertension and ascites in acute hepatitis: clinical, hemodynamic and histological correlations. Hepatology 1989; 10: 482–487.
Google Scholar | Crossref | Medline7. Owen, RL, Shapiro, H. Pleural effusion, rash and anergy in icteric hepatitis (letter). N Engl J Med 1974; 291: 963–963.
Google Scholar8. Gross, PA, Gerding, DN. Pleural effusion associated with viral hepatitis. Gastoenterology. 1971; 60: 898–902.
Google Scholar | Crossref | Medline9. Qin, C, Zhou, L, Hu, Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020; 15: 762–768.
Google Scholar | Crossref10. Lv, XH, Yang, JL, Deng, K. Clinical outcomes of COVID-19 patients with chronic hepatitis B virus infection still need to be explored. Clin Gastroenterol Hepatol 2020; 18: 3055–3056.
Google Scholar | Crossref | Medline11. Liu, R, Zhao, L, Cheng, X, et al. Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study. Liver Int 2021; 41: 720–730.
Google Scholar | Crossref | Medline12. Rodríguez-Tajes, S, Miralpeix, A, Costa, J, et al. Low risk of hepatitis b reactivation in patients with severe COVID-19 who receive immunosuppressive therapy. J Viral Hepat 2021; 28: 89–94.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif